Listen to Sean Kelly, MD, from The Ohio State University, review the current nomenclature and risk factors associated with MASLD. He discusses recommended screening and evaluation approaches and evidence-based therapies for management of metabolic liver disease in patients. Moderated by Deborah Gordish, MD, The Ohio State University Resources on this and other topics are available at www.Cardi-OH.org.
Information
- Show
- FrequencyUpdated Daily
- PublishedNovember 25, 2025 at 6:12 PM UTC
- Length22 min
- RatingClean
